NCT06221332

Brief Summary

Pregnant women feel severe pain during normal birth and in the postpartum period. Preventing pain during and after birth is very important for both the mother and the baby. Rapid recovery in the postoperative period in pregnant women is very important for both mother and baby. To evaluate this recovery, the quality of recovery-10 scores developed by Shalev et al. are used in pregnant women. Our study will be the first in the literature to use sacral erectör spinae plane block (S-ESPB) in normal birth. Our primary aim in this study is to evaluate the effects of S-ESPB on the quality of recovery and recovery at the 24th hour in pregnant women who will undergo vaginal birth with epidural analgesia, using the Quality of Recovery-10T scores.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 24, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2025

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

1.6 years

First QC Date

December 27, 2023

Last Update Submit

October 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery (10T) scores

    The primary evaluation criterion will be the recording of Quality of Recovery-10T scores, which indicate the quality of recovery of pregnant women at the 24th hour after birth. Quality of Recovery-10T ( Minumum: 0 = Very bad, Maximum: 100= Perfect).

    One day

Study Arms (2)

SACRAL EREKTÖR SPİNAE PLANE BLOK

ACTIVE COMPARATOR

Pregnant women in Group S will be given 10 cc bupivacaine solution of 0.25% bupivacaine on both sides.

Other: % 0.25 bupivakain 20cc

control group

ACTIVE COMPARATOR

Pregnant women in Group K will be injected with 10 cc of saline on both sides.

Other: 20 cc saline

Interventions

Pregnant women in group S will be given 0.25% bupivacaine, 10 cc on each side.

SACRAL EREKTÖR SPİNAE PLANE BLOK

Pregnant women in Group K will be given 10 cc of saline on both sides.

control group

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women who will have normal birth
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women who are their gestational age and request epidural anesthesia
  • Pregnant women aged 18-42 with ASA II
  • Pregnant women who will stay in the hospital for at least 24 hours
  • Primiparous pregnant women who will have a planned normal birth
  • Singleton births with vertex presentation

You may not qualify if:

  • Pregnant women who do not want to give consent
  • Regional anesthesia is contraindicated
  • Pregnant women who use anticoagulants and have an abnormal bleeding profile
  • Pregnant women with infection in the area to be treated
  • Emergency cases and pregnant women who had a birth with instruments (forceps and vacuum)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, 42020, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • MUHAMMED H SATICI, M.D.

    Konya City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MUHAMMED H SATICI, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist, M.D., Department of members Anesthesiology and Reanimation, Konya City Hospital, M.D

Study Record Dates

First Submitted

December 27, 2023

First Posted

January 24, 2024

Study Start

January 24, 2024

Primary Completion

September 15, 2025

Study Completion

November 15, 2025

Last Updated

October 8, 2024

Record last verified: 2024-10

Locations